Chong Wei

2.4k total citations
85 papers, 1.1k citations indexed

About

Chong Wei is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Chong Wei has authored 85 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pathology and Forensic Medicine, 24 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Chong Wei's work include Lymphoma Diagnosis and Treatment (31 papers), CNS Lymphoma Diagnosis and Treatment (12 papers) and Histone Deacetylase Inhibitors Research (11 papers). Chong Wei is often cited by papers focused on Lymphoma Diagnosis and Treatment (31 papers), CNS Lymphoma Diagnosis and Treatment (12 papers) and Histone Deacetylase Inhibitors Research (11 papers). Chong Wei collaborates with scholars based in China, United States and Taiwan. Chong Wei's co-authors include Hasan B. Alam, Baoling Liu, George C. Velmahos, Zhengcai Liu, Yongqing Li, Marc DeMoya, Guang Jin, Daobin Zhou, Ting C. Zhao and Jennifer Lu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Chong Wei

69 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chong Wei China 18 378 300 193 170 130 85 1.1k
Jamie R. Privratsky United States 21 477 1.3× 343 1.1× 98 0.5× 113 0.7× 138 1.1× 50 1.6k
Paul Brennan United Kingdom 18 184 0.5× 149 0.5× 108 0.6× 311 1.8× 334 2.6× 54 1.2k
Mariana Kiomy Osako Japan 20 421 1.1× 159 0.5× 111 0.6× 101 0.6× 88 0.7× 40 1.2k
Atsuko Sato Japan 19 333 0.9× 91 0.3× 131 0.7× 51 0.3× 112 0.9× 62 1.1k
Chrissa Sioka Greece 21 270 0.7× 88 0.3× 73 0.4× 237 1.4× 150 1.2× 85 1.4k
Jessica Li United States 12 195 0.5× 101 0.3× 88 0.5× 49 0.3× 105 0.8× 48 761
Lin Qiu China 12 268 0.7× 200 0.7× 50 0.3× 52 0.3× 41 0.3× 49 924
Lars Wennberg Sweden 24 273 0.7× 210 0.7× 116 0.6× 77 0.5× 116 0.9× 97 1.8k
Mark DeNichilo Australia 16 677 1.8× 175 0.6× 55 0.3× 170 1.0× 35 0.3× 25 1.2k

Countries citing papers authored by Chong Wei

Since Specialization
Citations

This map shows the geographic impact of Chong Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong Wei more than expected).

Fields of papers citing papers by Chong Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chong Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong Wei. The network helps show where Chong Wei may publish in the future.

Co-authorship network of co-authors of Chong Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Chong Wei. A scholar is included among the top collaborators of Chong Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chong Wei. Chong Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Wang, Yupeng, Chong Wei, Ziqian Wang, et al.. (2025). Linperlisib Plus Chidamide in Relapsed or Refractory Cutaneous T-Cell Lymphoma. JAMA Dermatology. 161(9). 923–923.
5.
Zhang, Jie, Wei Wang, Xin Liu, et al.. (2025). PDIA3 Inhibition Facilitates Sensitivity of IKE‐Induced Ferroptosis via STAT3/LCN2 Axis to Improve Glioblastoma Therapy. Advanced Science. 13(12). e14191–e14191.
6.
Wei, Chong, Wei Zhang, Daobin Zhou, et al.. (2025). Golidocitinib combined with CHOP in newly-diagnosed peripheral T-cell lymphoma: Preliminary Results from A phase 1/2 clinical trial. Blood. 146(Supplement 1). 6322–6322.
7.
Wei, Chong, Song Xue, Hao Cai, et al.. (2024). Germline defects of familial hemophagocytic lymphohistiocytosis-related genes presenting as adult-onset peripheral T-cell lymphoma. Frontiers in Immunology. 15. 1365975–1365975. 2 indexed citations
8.
Chen, Hongyun, Wei Wang, Chong Wei, et al.. (2024). Lymphoma relapse 1 year or later after immunochemotherapy in DLBCL patients: clinical features and outcome. Clinical and Experimental Medicine. 24(1). 48–48. 2 indexed citations
9.
Chen, Chao, Zhe Zhuang, Hao Cai, et al.. (2024). Plasma circulating tumour DNA is a better source for diagnosis and mutational analysis of IVLBCL than tissue DNA. Journal of Cellular and Molecular Medicine. 28(14). e18576–e18576. 5 indexed citations
10.
Zhang, Yan, Wei Wang, Chong Wei, et al.. (2024). The role of upfront lenalidomide maintenance for primary central nervous system lymphoma following first‐line methotrexate treatment: A retrospective study. Cancer Medicine. 13(9). e7193–e7193. 6 indexed citations
11.
Liu, Guangzhu, et al.. (2023). Design of a Spherical Ga2O3/ZnO Composite with a Snakeberry-like Structure for Methyl Orange Degradation. Water. 15(5). 952–952. 3 indexed citations
12.
Wei, Chong, Shuqing Wang, Yan Zhang, et al.. (2023). The intrinsic defects of T cells impact the efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma. Blood Cancer Journal. 13(1). 186–186. 7 indexed citations
13.
Wei, Chong, et al.. (2023). Mutation profiling, tumour burden assessment, outcome prediction and disease monitoring by circulating tumour DNA in peripheral T‐cell lymphoma. British Journal of Haematology. 202(1). 86–95. 9 indexed citations
14.
Shan, Zhongyan, Yushu Li, Yongze Li, et al.. (2023). Changing Iodine Status and the Incidence of Thyroid Disease in Mainland China: A Prospective 20-Year Follow-Up Study. Thyroid. 33(7). 858–866. 14 indexed citations
15.
Xiao, Ting, Chong Wei, Lihua Jiang, et al.. (2023). P/C collaborative optimization strategy to enhance electrochemical performance of CoO electrode. Journal of Alloys and Compounds. 969. 172305–172305. 7 indexed citations
16.
Xiao, Ting, Chong Wei, Sheng-Yu Chen, et al.. (2023). Activation-Assisted High-Concentration Phosphorus-Doping to Enhance the Electrochemical Performance of Cobalt Carbonate Hydroxide Hydrate. Inorganic Chemistry. 62(27). 10704–10712. 4 indexed citations
17.
Li, Yanan, et al.. (2022). Follicular Lymphoma in China: Systematic Evaluation of Follicular Lymphoma Prognostic Models. SHILAP Revista de lepidopterología. 3 indexed citations
18.
Zhao, Jianwei, Jiashu Yu, Zhongyan Shan, et al.. (2021). MicroRNA expression profiles of the thyroid after goiter formation and involution in rats under different iodine regimens. Endocrine. 73(3). 598–608. 2 indexed citations
19.
Zhang, Yan, Liang Wang, Jian Sun, et al.. (2020). Serum interleukin‐10 as a valuable biomarker for early diagnosis and therapeutic monitoring in intravascular large B‐cell lymphoma. SHILAP Revista de lepidopterología. 10(3). e131–e131. 4 indexed citations
20.
Man, Na, Haixia Guan, Zhongyan Shan, et al.. (2006). [Long-term effects of high iodine intake: inhibition of thyroid iodine uptake and organification in Wistar rats].. PubMed. 86(48). 3420–4. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026